Advertisement
Screener

Insight Molecular Diagnostics Inc. (IMDX) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1.7 / 5 stars · 24/70 Roast Me

Insight Molecular Diagnostics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

Insight Molecular Diagnostics Inc. (IMDX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.32 million shares for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-01.

Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2019-04-01

  • Insight Molecular Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-12-31 was 0.00 shares.
  • Insight Molecular Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-09-30 was 197.95K shares.
  • Insight Molecular Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 1.32M shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month
2018-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
197.95K shares
derived: sum of 2 quarters · filed 2019-04-01
1.32M shares
10-K · filed 2019-04-01
2018-09-30197.95K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
1.32M shares
10-Q · filed 2018-11-13
2018-06-301.12M shares
10-Q · filed 2018-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92